3.26.1 html 311 224 1 false 74 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://galectintherapeutics.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://galectintherapeutics.com/role/ConsolidatedBalanceSheet CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parentheticals) Sheet http://galectintherapeutics.com/role/ConsolidatedBalanceSheet_Parentheticals CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://galectintherapeutics.com/role/ConsolidatedIncomeStatement CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://galectintherapeutics.com/role/ConsolidatedCashFlow CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) Sheet http://galectintherapeutics.com/role/ShareholdersEquityType2or3 CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) Statements 6 false false R7.htm 006 - Disclosure - Basis of Presentation and Liquidity Sheet http://galectintherapeutics.com/role/BasisofPresentationandLiquidity Basis of Presentation and Liquidity Notes 7 false false R8.htm 007 - Disclosure - Accrued Expenses and Other Sheet http://galectintherapeutics.com/role/AccruedExpensesandOther Accrued Expenses and Other Notes 8 false false R9.htm 008 - Disclosure - Convertible Notes Payable ??? Related Party Notes http://galectintherapeutics.com/role/ConvertibleNotesPayableRelatedParty Convertible Notes Payable ??? Related Party Notes 9 false false R10.htm 009 - Disclosure - Fair Value of Financial Instruments Sheet http://galectintherapeutics.com/role/FairValueofFinancialInstruments Fair Value of Financial Instruments Notes 10 false false R11.htm 010 - Disclosure - Stock-Based Compensation Sheet http://galectintherapeutics.com/role/StockBasedCompensation Stock-Based Compensation Notes 11 false false R12.htm 011 - Disclosure - Common Stock Warrants Sheet http://galectintherapeutics.com/role/CommonStockWarrants Common Stock Warrants Notes 12 false false R13.htm 012 - Disclosure - Loss Per Share Sheet http://galectintherapeutics.com/role/LossPerShare Loss Per Share Notes 13 false false R14.htm 013 - Disclosure - Common Stock Sheet http://galectintherapeutics.com/role/CommonStock Common Stock Notes 14 false false R15.htm 014 - Disclosure - Convertible Line of Credit - Related Party and Supplemental Convertible Lines of Credit - Related Party Sheet http://galectintherapeutics.com/role/ConvertibleLineofCreditRelatedPartyandSupplementalConvertibleLinesofCreditRelatedParty Convertible Line of Credit - Related Party and Supplemental Convertible Lines of Credit - Related Party Notes 15 false false R16.htm 015 - Disclosure - Segments Sheet http://galectintherapeutics.com/role/Segments Segments Notes 16 false false R17.htm 016 - Disclosure - Commitments and Contingencies Sheet http://galectintherapeutics.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 017 - Disclosure - Leases Sheet http://galectintherapeutics.com/role/Leases Leases Notes 18 false false R19.htm 018 - Disclosure - Galectin Sciences LLC Sheet http://galectintherapeutics.com/role/GalectinSciencesLLC Galectin Sciences LLC Notes 19 false false R20.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 20 false false R21.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 21 false false R22.htm 996000 - Disclosure - Accrued Expenses and Other (Tables) Sheet http://galectintherapeutics.com/role/AccruedExpensesandOtherTables Accrued Expenses and Other (Tables) Tables http://galectintherapeutics.com/role/AccruedExpensesandOther 22 false false R23.htm 996001 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://galectintherapeutics.com/role/FairValueofFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://galectintherapeutics.com/role/FairValueofFinancialInstruments 23 false false R24.htm 996002 - Disclosure - Stock-Based Compensation (Tables) Sheet http://galectintherapeutics.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://galectintherapeutics.com/role/StockBasedCompensation 24 false false R25.htm 996003 - Disclosure - Common Stock Warrants (Tables) Sheet http://galectintherapeutics.com/role/CommonStockWarrantsTables Common Stock Warrants (Tables) Tables http://galectintherapeutics.com/role/CommonStockWarrants 25 false false R26.htm 996004 - Disclosure - Loss Per Share (Tables) Sheet http://galectintherapeutics.com/role/LossPerShareTables Loss Per Share (Tables) Tables http://galectintherapeutics.com/role/LossPerShare 26 false false R27.htm 996005 - Disclosure - Segments (Tables) Sheet http://galectintherapeutics.com/role/SegmentsTables Segments (Tables) Tables http://galectintherapeutics.com/role/Segments 27 false false R28.htm 996006 - Disclosure - Basis of Presentation and Liquidity (Details) Sheet http://galectintherapeutics.com/role/BasisofPresentationandLiquidityDetails Basis of Presentation and Liquidity (Details) Details http://galectintherapeutics.com/role/BasisofPresentationandLiquidity 28 false false R29.htm 996007 - Disclosure - Accrued Expenses and Other - Accrued Expenses (Details) Sheet http://galectintherapeutics.com/role/AccruedExpensesTable Accrued Expenses and Other - Accrued Expenses (Details) Details 29 false false R30.htm 996008 - Disclosure - Convertible Notes Payable ??? Related Party (Details) Notes http://galectintherapeutics.com/role/ConvertibleNotesPayableRelatedPartyDetails Convertible Notes Payable ??? Related Party (Details) Details http://galectintherapeutics.com/role/ConvertibleNotesPayableRelatedParty 30 false false R31.htm 996009 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://galectintherapeutics.com/role/FairValueofFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) Details http://galectintherapeutics.com/role/FairValueofFinancialInstrumentsTables 31 false false R32.htm 996010 - Disclosure - Fair Value of Financial Instruments - Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Details) Sheet http://galectintherapeutics.com/role/AssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisTable Fair Value of Financial Instruments - Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Details) Details 32 false false R33.htm 996011 - Disclosure - Fair Value of Financial Instruments - April Note, Key Assumptions (Details) Sheet http://galectintherapeutics.com/role/AprilNoteKeyAssumptionsTable Fair Value of Financial Instruments - April Note, Key Assumptions (Details) Details 33 false false R34.htm 996012 - Disclosure - Fair Value of Financial Instruments - Roll Forward of April Note Derivative Liability (Details) Sheet http://galectintherapeutics.com/role/RollForwardofAprilNoteDerivativeLiabilityTable Fair Value of Financial Instruments - Roll Forward of April Note Derivative Liability (Details) Details 34 false false R35.htm 996013 - Disclosure - Fair Value of Financial Instruments - September Note, Key Assumptions (Details) Sheet http://galectintherapeutics.com/role/SeptemberNoteKeyAssumptionsTable Fair Value of Financial Instruments - September Note, Key Assumptions (Details) Details 35 false false R36.htm 996014 - Disclosure - Fair Value of Financial Instruments - Roll Forward of September Note Derivative Liability (Details) Sheet http://galectintherapeutics.com/role/RollForwardofSeptemberNoteDerivativeLiabilityTable Fair Value of Financial Instruments - Roll Forward of September Note Derivative Liability (Details) Details 36 false false R37.htm 996015 - Disclosure - Fair Value of Financial Instruments - December Note, Key Assumptions (Details) Sheet http://galectintherapeutics.com/role/DecemberNoteKeyAssumptionsTable Fair Value of Financial Instruments - December Note, Key Assumptions (Details) Details 37 false false R38.htm 996016 - Disclosure - Fair Value of Financial Instruments - Roll Forward of December Note Derivative Liability (Details) Sheet http://galectintherapeutics.com/role/RollForwardofDecemberNoteDerivativeLiabilityTable Fair Value of Financial Instruments - Roll Forward of December Note Derivative Liability (Details) Details 38 false false R39.htm 996017 - Disclosure - Stock-Based Compensation (Details) Sheet http://galectintherapeutics.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://galectintherapeutics.com/role/StockBasedCompensationTables 39 false false R40.htm 996018 - Disclosure - Stock-Based Compensation - Components of Stock-Based Compensation Expense (Details) Sheet http://galectintherapeutics.com/role/ComponentsofStockBasedCompensationExpenseTable Stock-Based Compensation - Components of Stock-Based Compensation Expense (Details) Details 40 false false R41.htm 996019 - Disclosure - Stock-Based Compensation - Stock Option Activity (Details) Sheet http://galectintherapeutics.com/role/StockOptionActivityTable Stock-Based Compensation - Stock Option Activity (Details) Details 41 false false R42.htm 996020 - Disclosure - Stock-Based Compensation - Weighted Average Assumptions Used to Determine Fair Value of Options Granted (Details) Sheet http://galectintherapeutics.com/role/WeightedAverageAssumptionsUsedtoDetermineFairValueofOptionsGrantedTable Stock-Based Compensation - Weighted Average Assumptions Used to Determine Fair Value of Options Granted (Details) Details 42 false false R43.htm 996021 - Disclosure - Common Stock Warrants (Details) Sheet http://galectintherapeutics.com/role/CommonStockWarrantsDetails Common Stock Warrants (Details) Details http://galectintherapeutics.com/role/CommonStockWarrantsTables 43 false false R44.htm 996022 - Disclosure - Common Stock Warrants - Common Stock Warrants (Details) Sheet http://galectintherapeutics.com/role/CommonStockWarrantsTable Common Stock Warrants - Common Stock Warrants (Details) Details 44 false false R45.htm 996023 - Disclosure - Loss Per Share - Loss Per Share (Details) Sheet http://galectintherapeutics.com/role/LossPerShareTable Loss Per Share - Loss Per Share (Details) Details 45 false false R46.htm 996024 - Disclosure - Common Stock (Details) Sheet http://galectintherapeutics.com/role/CommonStockDetails Common Stock (Details) Details http://galectintherapeutics.com/role/CommonStockWarrantsTables 46 false false R47.htm 996025 - Disclosure - Convertible Line of Credit - Related Party and Supplemental Convertible Lines of Credit - Related Party (Details) Sheet http://galectintherapeutics.com/role/ConvertibleLineofCreditRelatedPartyandSupplementalConvertibleLinesofCreditRelatedPartyDetails Convertible Line of Credit - Related Party and Supplemental Convertible Lines of Credit - Related Party (Details) Details http://galectintherapeutics.com/role/ConvertibleLineofCreditRelatedPartyandSupplementalConvertibleLinesofCreditRelatedParty 47 false false R48.htm 996026 - Disclosure - Segments (Details) Sheet http://galectintherapeutics.com/role/SegmentsDetails Segments (Details) Details http://galectintherapeutics.com/role/SegmentsTables 48 false false R49.htm 996027 - Disclosure - Segments - Significant Expense and Asset Categories (Details) Sheet http://galectintherapeutics.com/role/SignificantExpenseandAssetCategoriesTable Segments - Significant Expense and Asset Categories (Details) Details 49 false false R50.htm 996028 - Disclosure - Commitments and Contingencies (Details) Sheet http://galectintherapeutics.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://galectintherapeutics.com/role/CommitmentsandContingencies 50 false false R51.htm 996029 - Disclosure - Leases (Details) Sheet http://galectintherapeutics.com/role/LeasesDetails Leases (Details) Details http://galectintherapeutics.com/role/Leases 51 false false R52.htm 996030 - Disclosure - Galectin Sciences LLC (Details) Sheet http://galectintherapeutics.com/role/GalectinSciencesLLCDetails Galectin Sciences LLC (Details) Details http://galectintherapeutics.com/role/GalectinSciencesLLC 52 false false All Reports Book All Reports ef20070490_10q.htm galt-20260331.xsd galt-20260331_cal.xml galt-20260331_def.xml galt-20260331_lab.xml galt-20260331_pre.xml http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true